行情

MYOS

MYOS

MYOS RENS
NASDAQ

实时行情|Nasdaq Last Sale

1.433
-0.017
-1.17%
盘后: 1.420 -0.013 -0.91% 18:29 10/14 EDT
开盘
1.550
昨收
1.450
最高
1.550
最低
1.420
成交量
1.27万
成交额
--
52周最高
2.020
52周最低
1.040
市值
1,314.16万
市盈率(TTM)
-3.7124
分时
5日
1月
3月
1年
5年

EPS

MYOS 新闻

  • 无惧脱欧风险 伦敦外汇市场反而吸引大批交易者
  • 新浪财经综合.1小时前
  • WeWork办公场所发现高浓度甲醛 关闭2300个电话亭
  • 新浪财经.1小时前
  • “脱欧”致英国在德国贸易地位下降
  • 新华网.1小时前
  • "满血复活" 沙特本月石油产量将高于遇袭前水平
  • 环球外汇网官网.1小时前

更多

所属板块

食品加工
-0.51%
食品和烟类
-0.31%

热门股票

名称
价格
涨跌幅

MYOS 简况

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. The Company is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue. MYOS is evaluating the modulation of myostatin. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement.
展开

Webull提供MYOS RENS Technology Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。